Dow Today: Pfizer (PFE) Leads The Day Higher, Wal-Mart Stores (WMT) Lags

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

The Dow Jones Industrial Average (^DJI) is trading up one points at 13,974 as of Friday, Feb 15, 2013, 9:35 a.m. ET. During this time, 91.4 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 619.1 million. The NYSE advances/declines ratio sits at 1,410 issues advancing vs. 985 declining with 185 unchanged.

• EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component leading the way higher looks to be Pfizer (NYSE:PFE), which is sporting a 12-cent gain (+0.4%) bringing the stock to $27.18. This single gain is lifting the Dow Jones Industrial Average by 0.91 points or roughly accounting for 91% of the Dow's overall gain. Volume for Pfizer currently sits at 5.8 million shares traded vs. an average daily trading volume of 32.7 million shares.

Pfizer has a market cap of $198.79 billion and is part of the health care sector and drugs industry. Shares are up 7.7% year to date as of Thursday's close. The stock's dividend yield sits at 3.6%.

Pfizer Inc., a biopharmaceutical company, engages in the discovery, development, manufacture, and sale of medicines for people and animals worldwide. The company has a P/E ratio of 21.4, above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Pfizer as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, compelling growth in net income and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

• You can view the full Pfizer Ratings Report.

Holding back the Dow today is Wal-Mart Stores (NYSE:WMT), which is lagging the broader Dow index with a $1.38 decline (-1.9%) bringing the stock to $69.44. Volume for Wal-Mart Stores currently sits at 2.7 million shares traded vs. an average daily trading volume of 8.5 million shares.

• See our dividend calendar or top-yielding stocks list.

Wal-Mart Stores has a market cap of $238.82 billion and is part of the services sector and retail industry. Shares are up 4.6% year to date as of Thursday's close. The stock's dividend yield sits at 2.2%.

Wal-Mart Stores, Inc. operates retail stores in various formats worldwide. It operates retail stores, restaurants, discount stores, supermarkets, supercenters, hypermarkets, warehouse clubs, apparel stores, Sam's Clubs, and neighborhood markets, as well as walmart.com; and samsclub.com. The company has a P/E ratio of 14.7, below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Wal-Mart Stores as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, revenue growth, increase in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins.

• You can view the full Wal-Mart Stores Ratings Report.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.

For more information on Pfizer Inc click any of the following:

• Pfizer Inc Stock Price

• Pfizer Inc Analyst Ratings

• Pfizer Inc Key Stats & Profile

• Pfizer Inc Earnings

• Pfizer Inc Ratio Comparison

• Pfizer Inc Growth Rates

• Pfizer Inc Balance Sheet

• Pfizer Inc Cash Flow

• Pfizer Inc Income Statement